All modalities are compared with the technetium 99m sestamibi (MIBI) single-photon emission computed tomography (SPECT) category. 95% CrI indicates 95% credible interval; CT, computed tomography; MET, carbon 11–labeled methionine; MRI, magnetic resonance imaging; PET, positron emission tomography; and US, ultrasonography.